|
Q1 FY2026
As of Jan 31, 2026
|
Q4 FY2025
As of Oct 31, 2025
|
Q3 FY2025
As of Jul 31, 2025
|
Q2 FY2025
As of Apr 30, 2025
|
Q1 FY2025
As of Jan 31, 2025
|
Q4 FY2024
As of Oct 31, 2024
|
Q3 FY2024
As of Jul 31, 2024
|
Q2 FY2024
As of Apr 30, 2024
|
Q1 FY2024
As of Jan 31, 2024
|
Q4 FY2023
As of Oct 31, 2023
|
Q3 FY2023
As of Jul 31, 2023
|
Q2 FY2023
As of Apr 30, 2023
|
Q1 FY2023
As of Jan 31, 2023
|
Q4 FY2022
As of Oct 31, 2022
|
Q3 FY2022
As of Jul 31, 2022
|
Q2 FY2022
As of Apr 30, 2022
|
Q1 FY2022
As of Jan 31, 2022
|
Q4 FY2021
As of Oct 31, 2021
|
Q3 FY2021
As of Jul 31, 2021
|
Q2 FY2021
As of Apr 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowances of $2,539 (2026) and $3,336 (2025) | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Advances to suppliers | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Investments in unconsolidated entities | ||||||||||||||||||||
| Deferred income tax assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Non-current assets held for sale | ||||||||||||||||||||
| Intangibles, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and shareholders' equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Payable to growers | ||||||||||||||||||||
| Trade accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Current liabilities held for sale | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Current portion of term loan | ||||||||||||||||||||
| Mexico tax liability | ||||||||||||||||||||
| Current portion of operating leases | ||||||||||||||||||||
| Current portion of finance leases | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Borrowings pursuant to credit facilities, long-term | ||||||||||||||||||||
| Borrowings pursuant to line of credit, long-term | ||||||||||||||||||||
| Long-term liabilities held for sale | ||||||||||||||||||||
| Long-term portion of term loan | ||||||||||||||||||||
| Long-term portion of operating leases | ||||||||||||||||||||
| Long-term portion of finance leases | ||||||||||||||||||||
| Deferred income tax liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Common stock ($0.001 par value, 100,000 shares authorized; 17,874 (2026) and 17,855 (2025) shares issued and outstanding) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total Calavo Growers, Inc. shareholders' equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
